Mass Spectrometry Market Size to Reach USD 10.13 Billion by 2030, Fueled by AI, Multi-Omics, and Next-Gen Healthcare | Mordor Intelligence
HYDERABAD, India, Sept. 2, 2025 /PRNewswire/ — According to Mordor Intelligence, the global mass spectrometry market, valued at USD 7.16 billion in 2025,... Read more.
ChipMOS ANNOUNCES NT$480 MILLION SHARE REPURCHASE PROGRAM
HSINCHU, Sept. 2, 2025 /PRNewswire-FirstCall/ — ChipMOS TECHNOLOGIES INC. (“ChipMOS” or the “Company”) (Taiwan Stock Exchange: 8150... Read more.
Digital Turbine Announces Successful Completion of Debt Refinancing and Updates Annual Guidance
The company has secured a new four-year credit facility following strong fiscal first quarter results and the issuance of fiscal year 2026 annual... Read more.
Eluvio Unveils Live Broadcast Distribution to Replace Satellite and Fiber Point-to-Point at IBC 2025
New capability replaces costly satellite and peer-to-peer fiber with Live Broadcast Feed Distribution (SMPTE 2110/2022 JPEG-XS/SRT/RTP) via the Eluvio Content Fabric... Read more.
Stellar Tech acquires Join to create the leading creator marketplace in the Benelux
BRUSSELS, Sept. 2, 2025 /PRNewswire/ — Stellar Tech, the European leader in influencer marketing technology, has acquired Join, the Dutch leading creator... Read more.
Arelion Announces Major Scandinavian Fiber Upgrade To Meet AI Demand and Drive Regional Growth
STOCKHOLM, Sept. 2, 2025 /PRNewswire/ — Arelion today announced major fiber investments in its extensive Scandinavian network to connect hyperscale... Read more.
FORVIA HELLA and Tau Motors partner to develop advanced charging solutions
Focus: development of a Virtually Isolated Onboard Charger (viOBC) Features: high power density and energy efficiency Product design: space requirement halved; weight... Read more.
Servier and IDEAYA Biosciences Partner to Bring Darovasertib, a Promising Uveal Melanoma Treatment, to Patients Worldwide
Servier and IDEAYA Biosciences enter into an exclusive license agreement for regulatory and commercial rights to darovasertib outside the US Darovasertib is a small... Read more.
ADNOC CEO Dr Sultan Al Jaber is the 2025 ICIS CEO of the Year
LONDON and NEW YORK, Sept. 2, 2025 /PRNewswire/ — ICIS is pleased to announce Dr. Sultan Ahmed Al Jaber, UAE Minister of Industry and Advanced Technology,... Read more.
Ascletis to Present 28-day Multiple Ascending Dose Study Results of Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting
– Ascletis to present data from the U.S. Phase Ib clinical study of ASC30 oral tablet in oral discussion – On track to report topline data from Phase... Read more.